Global OTC Anti-Infective Medications Market Research Report 2022

SKU ID : QYR-21449028 | Publishing Date : 10-Aug-2022 | No. of pages : 87

Request a free Sample

Detailed TOC of Global OTC Anti-Infective Medications Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antifungals
        1.2.3 Antiseptic
        1.2.4 Antiparasitics
    1.3 Market by Application
        1.3.1 Global OTC Anti-Infective Medications Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 E-Commerce
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global OTC Anti-Infective Medications Market Perspective (2017-2028)
    2.2 OTC Anti-Infective Medications Growth Trends by Region
        2.2.1 OTC Anti-Infective Medications Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2017-2022)
        2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2023-2028)
    2.3 OTC Anti-Infective Medications Market Dynamics
        2.3.1 OTC Anti-Infective Medications Industry Trends
        2.3.2 OTC Anti-Infective Medications Market Drivers
        2.3.3 OTC Anti-Infective Medications Market Challenges
        2.3.4 OTC Anti-Infective Medications Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top OTC Anti-Infective Medications Players by Revenue
        3.1.1 Global Top OTC Anti-Infective Medications Players by Revenue (2017-2022)
        3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2017-2022)
    3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by OTC Anti-Infective Medications Revenue
    3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
        3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2021
    3.5 OTC Anti-Infective Medications Key Players Head office and Area Served
    3.6 Key Players OTC Anti-Infective Medications Product Solution and Service
    3.7 Date of Enter into OTC Anti-Infective Medications Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medications Breakdown Data by Type
    4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2017-2022)
    4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2023-2028)
5 OTC Anti-Infective Medications Breakdown Data by Application
    5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2017-2022)
    5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America OTC Anti-Infective Medications Market Size (2017-2028)
    6.2 North America OTC Anti-Infective Medications Market Size by Country (2017-2022)
    6.3 North America OTC Anti-Infective Medications Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe OTC Anti-Infective Medications Market Size (2017-2028)
    7.2 Europe OTC Anti-Infective Medications Market Size by Country (2017-2022)
    7.3 Europe OTC Anti-Infective Medications Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific OTC Anti-Infective Medications Market Size (2017-2028)
    8.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2017-2022)
    8.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America OTC Anti-Infective Medications Market Size (2017-2028)
    9.2 Latin America OTC Anti-Infective Medications Market Size by Country (2017-2022)
    9.3 Latin America OTC Anti-Infective Medications Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa OTC Anti-Infective Medications Market Size (2017-2028)
    10.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2017-2022)
    10.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Detail
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
        11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck OTC Anti-Infective Medications Introduction
        11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer OTC Anti-Infective Medications Introduction
        11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis OTC Anti-Infective Medications Introduction
        11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Abbott
        11.5.1 Abbott Company Detail
        11.5.2 Abbott Business Overview
        11.5.3 Abbott OTC Anti-Infective Medications Introduction
        11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.5.5 Abbott Recent Development
    11.6 Sanofi
        11.6.1 Sanofi Company Detail
        11.6.2 Sanofi Business Overview
        11.6.3 Sanofi OTC Anti-Infective Medications Introduction
        11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.6.5 Sanofi Recent Development
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Detail
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
        11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Recent Development
    11.8 Roche
        11.8.1 Roche Company Detail
        11.8.2 Roche Business Overview
        11.8.3 Roche OTC Anti-Infective Medications Introduction
        11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.8.5 Roche Recent Development
    11.9 NanoViricides
        11.9.1 NanoViricides Company Detail
        11.9.2 NanoViricides Business Overview
        11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
        11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.9.5 NanoViricides Recent Development
    11.10 Novabay Pharmaceuticals
        11.10.1 Novabay Pharmaceuticals Company Detail
        11.10.2 Novabay Pharmaceuticals Business Overview
        11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
        11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.10.5 Novabay Pharmaceuticals Recent Development
    11.11 Optimer Pharmaceuticals
        11.11.1 Optimer Pharmaceuticals Company Detail
        11.11.2 Optimer Pharmaceuticals Business Overview
        11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
        11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.11.5 Optimer Pharmaceuticals Recent Development
    11.12 Basilea Pharmaceutica
        11.12.1 Basilea Pharmaceutica Company Detail
        11.12.2 Basilea Pharmaceutica Business Overview
        11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
        11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.12.5 Basilea Pharmaceutica Recent Development
    11.13 MerLion Pharma
        11.13.1 MerLion Pharma Company Detail
        11.13.2 MerLion Pharma Business Overview
        11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
        11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2017-2022)
        11.13.5 MerLion Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global OTC Anti-Infective Medications Market Research Report 2022

List of Tables
    Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antifungals
    Table 3. Key Players of Antiseptic
    Table 4. Key Players of Antiparasitics
    Table 5. Global OTC Anti-Infective Medications Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global OTC Anti-Infective Medications Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global OTC Anti-Infective Medications Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global OTC Anti-Infective Medications Market Share by Region (2017-2022)
    Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global OTC Anti-Infective Medications Market Share by Region (2023-2028)
    Table 11. OTC Anti-Infective Medications Market Trends
    Table 12. OTC Anti-Infective Medications Market Drivers
    Table 13. OTC Anti-Infective Medications Market Challenges
    Table 14. OTC Anti-Infective Medications Market Restraints
    Table 15. Global OTC Anti-Infective Medications Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global OTC Anti-Infective Medications Market Share by Players (2017-2022)
    Table 17. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2021)
    Table 18. Ranking of Global Top OTC Anti-Infective Medications Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players OTC Anti-Infective Medications Product Solution and Service
    Table 22. Date of Enter into OTC Anti-Infective Medications Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2017-2022)
    Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2023-2028)
    Table 28. Global OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global OTC Anti-Infective Medications Revenue Market Share by Application (2017-2022)
    Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global OTC Anti-Infective Medications Revenue Market Share by Application (2023-2028)
    Table 32. North America OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 42. GlaxoSmithKline Company Detail
    Table 43. GlaxoSmithKline Business Overview
    Table 44. GlaxoSmithKline OTC Anti-Infective Medications Product
    Table 45. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 46. GlaxoSmithKline Recent Development
    Table 47. Merck Company Detail
    Table 48. Merck Business Overview
    Table 49. Merck OTC Anti-Infective Medications Product
    Table 50. Merck Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 51. Merck Recent Development
    Table 52. Pfizer Company Detail
    Table 53. Pfizer Business Overview
    Table 54. Pfizer OTC Anti-Infective Medications Product
    Table 55. Pfizer Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 56. Pfizer Recent Development
    Table 57. Novartis Company Detail
    Table 58. Novartis Business Overview
    Table 59. Novartis OTC Anti-Infective Medications Product
    Table 60. Novartis Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 61. Novartis Recent Development
    Table 62. Abbott Company Detail
    Table 63. Abbott Business Overview
    Table 64. Abbott OTC Anti-Infective Medications Product
    Table 65. Abbott Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. Sanofi Company Detail
    Table 68. Sanofi Business Overview
    Table 69. Sanofi OTC Anti-Infective Medications Product
    Table 70. Sanofi Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. Bristol-Myers Squibb Company Detail
    Table 73. Bristol-Myers Squibb Business Overview
    Table 74. Bristol-Myers Squibb OTC Anti-Infective Medications Product
    Table 75. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 76. Bristol-Myers Squibb Recent Development
    Table 77. Roche Company Detail
    Table 78. Roche Business Overview
    Table 79. Roche OTC Anti-Infective Medications Product
    Table 80. Roche Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 81. Roche Recent Development
    Table 82. NanoViricides Company Detail
    Table 83. NanoViricides Business Overview
    Table 84. NanoViricides OTC Anti-Infective Medications Product
    Table 85. NanoViricides Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 86. NanoViricides Recent Development
    Table 87. Novabay Pharmaceuticals Company Detail
    Table 88. Novabay Pharmaceuticals Business Overview
    Table 89. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
    Table 90. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 91. Novabay Pharmaceuticals Recent Development
    Table 92. Optimer Pharmaceuticals Company Detail
    Table 93. Optimer Pharmaceuticals Business Overview
    Table 94. Optimer Pharmaceuticals OTC Anti-Infective MedicationsProduct
    Table 95. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 96. Optimer Pharmaceuticals Recent Development
    Table 97. Basilea Pharmaceutica Company Detail
    Table 98. Basilea Pharmaceutica Business Overview
    Table 99. Basilea Pharmaceutica OTC Anti-Infective MedicationsProduct
    Table 100. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 101. Basilea Pharmaceutica Recent Development
    Table 102. MerLion Pharma Company Detail
    Table 103. MerLion Pharma Business Overview
    Table 104. MerLion Pharma OTC Anti-Infective MedicationsProduct
    Table 105. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
    Table 106. MerLion Pharma Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global OTC Anti-Infective Medications Market Share by Type: 2021 VS 2028
    Figure 2. Antifungals Features
    Figure 3. Antiseptic Features
    Figure 4. Antiparasitics Features
    Figure 5. Global OTC Anti-Infective Medications Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Drug Stores Case Studies
    Figure 8. E-Commerce Case Studies
    Figure 9. OTC Anti-Infective Medications Report Years Considered
    Figure 10. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global OTC Anti-Infective Medications Market Share by Region: 2021 VS 2028
    Figure 13. Global OTC Anti-Infective Medications Market Share by Players in 2021
    Figure 14. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2021
    Figure 16. North America OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America OTC Anti-Infective Medications Market Share by Country (2017-2028)
    Figure 18. United States OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe OTC Anti-Infective Medications Market Share by Country (2017-2028)
    Figure 22. Germany OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific OTC Anti-Infective Medications Market Share by Region (2017-2028)
    Figure 30. China OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America OTC Anti-Infective Medications Market Share by Country (2017-2028)
    Figure 38. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2017-2028)
    Figure 42. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 45. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 46. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 48. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 49. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 50. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 51. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 52. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 53. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 54. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 55. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 56. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed

Keyplayers in Global OTC Anti-Infective Medications Market Research Report 2022

GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma